ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1030

Predictors of Incident Atrial Fibrillation in Rheumatoid Arthritis Patients: A Population Based Cohort Study

Sarah Pimple1, Alanna Chamberlain1, Sara Achenbach2, Cynthia Crowson3 and Elena myasoedova1, 1Mayo Clinic, Rochester, MN, 2Mayo Clinic, Rochester, 3Mayo Clinic, Stewartvillle, MN

Meeting: ACR Convergence 2025

Keywords: Heart disease, rheumatoid arthritis, risk factors

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (1007–1037) Epidemiology & Public Health Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Rheumatoid arthritis (RA) has been associated with an increased risk of developing atrial fibrillation (AF). However, recent data on trends in incidence of AF and risk factors associated with AF in RA from population-based cohorts are lacking. This study seeks to assess the risk of AF in patients with RA compared to the general population and identify predictors of AF in patients with RA.

Methods: Retrospective medical records review was completed to form an inception cohort of all patients with RA in 1990-2019, among residents of a geographically defined area, aged ≥18 years. The incidence date of RA was defined as the earliest date at which the patient fulfilled the 1987 or 2010 classification criteria for RA. Each patient with RA was matched on age, sex, year, and county to a randomly selected comparator without RA (using the date of RA as the index date for the matched referent without RA). Patients were followed until diagnosis of new-onset AF, death, migration, or 12/31/2023. AF was defined using a previously published electronic algorithm. Descriptive statistics and Cox models adjusted for age, sex, and calendar year of RA incidence were conducted.

Results: 3798 patients were included, with 1899 patients with RA and 1899 patients without RA (mean age 55.9 years, 68% female). RA status was not found to be a significant risk factor to predict AF (adjusted for age, sex, calendar year, smoking status, and obesity) (HR 1.10; 95% CI 0.92-1.33). Among patients with RA, significant risk factors associated with incident AF included age (HR:2.29 per 10 year increase; 95%CI:2.05-2.56), male sex (HR:1.57; 95%CI:1.22-2.03), former smoking (HR:1.35; 95%CI:1.01-1.81), current smoking (HR:2.16, 95%CI:1.51-3.09), obesity (HR:1.83, 95%CI:1.42-2.37), diabetes (HR:1.54, 95%CI:1.09-2.17), and hypertension (HR:1.60, 95%CI:1.20-2.13). Additionally, for patients with RA the following disease characteristics were associated with increased risk of AF: radiographic joint erosions or destructive changes (HR 1.36; 95% CI 1.03-1.79), rheumatoid nodules (HR 1.70; 95% CI 1.19-2.43), large joint swelling (HR 1.35; 95% CI 1.04-1.76), and severe extra-articular manifestations (HR 2.03; 95% CI 1.31-3.14).

Conclusion: While RA was not a risk factor for AF, adverse cardiovascular risk profile and RA disease severity significantly increased the risk of AF among patients with RA. Future studies will inform to what extent early recognition and management of these risk factors can help improve AF outcomes in RA.


Disclosures: S. Pimple: None; A. Chamberlain: None; S. Achenbach: None; C. Crowson: None; E. myasoedova: None.

To cite this abstract in AMA style:

Pimple S, Chamberlain A, Achenbach S, Crowson C, myasoedova E. Predictors of Incident Atrial Fibrillation in Rheumatoid Arthritis Patients: A Population Based Cohort Study [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/predictors-of-incident-atrial-fibrillation-in-rheumatoid-arthritis-patients-a-population-based-cohort-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/predictors-of-incident-atrial-fibrillation-in-rheumatoid-arthritis-patients-a-population-based-cohort-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology